Suhan Ni

Array ( [id] => 4792746 [patent_doc_number] => 20080293720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Pyridinyl Sulfonamide Modulators of Chemokine Receptors' [patent_app_type] => utility [patent_app_number] => 12/096185 [patent_app_country] => US [patent_app_date] => 2006-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14189 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293720.pdf [firstpage_image] =>[orig_patent_app_number] => 12096185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682914 [patent_doc_number] => 20080249140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents' [patent_app_type] => utility [patent_app_number] => 12/094169 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3915 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249140.pdf [firstpage_image] =>[orig_patent_app_number] => 12094169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343318 [patent_doc_number] => 20090181968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides' [patent_app_type] => utility [patent_app_number] => 12/094334 [patent_app_country] => US [patent_app_date] => 2006-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33311 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181968.pdf [firstpage_image] =>[orig_patent_app_number] => 12094334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989625 [patent_doc_number] => 20070155966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Pyridyl Substituted Heterocycles Useful For Treating Or Preventing HCV Infection' [patent_app_type] => utility [patent_app_number] => 11/561991 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 20707 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155966.pdf [firstpage_image] =>[orig_patent_app_number] => 11561991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519059 [patent_doc_number] => 07973161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/600445 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 156779 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 420 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973161.pdf [firstpage_image] =>[orig_patent_app_number] => 11600445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519059 [patent_doc_number] => 07973161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Apoptosis promoters' [patent_app_type] => utility [patent_app_number] => 11/600445 [patent_app_country] => US [patent_app_date] => 2006-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 156779 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 420 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973161.pdf [firstpage_image] =>[orig_patent_app_number] => 11600445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534850 [patent_doc_number] => 07888376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Heterocyclic CETP inhibitors' [patent_app_type] => utility [patent_app_number] => 11/559930 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 157168 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888376.pdf [firstpage_image] =>[orig_patent_app_number] => 11559930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4579477 [patent_doc_number] => 07833999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics' [patent_app_type] => utility [patent_app_number] => 11/559929 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7088 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833999.pdf [firstpage_image] =>[orig_patent_app_number] => 11559929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057835 [patent_doc_number] => 20070060757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Synthesis of enantiomerically pure amino-substituted fused bicyclic rings' [patent_app_type] => utility [patent_app_number] => 11/598955 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21595 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060757.pdf [firstpage_image] =>[orig_patent_app_number] => 11598955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792735 [patent_doc_number] => 20080293709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies' [patent_app_type] => utility [patent_app_number] => 12/093631 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39443 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293709.pdf [firstpage_image] =>[orig_patent_app_number] => 12093631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853252 [patent_doc_number] => 20080318995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'N-Substituted Indenoisoquinolines and Syntheses Thereof' [patent_app_type] => utility [patent_app_number] => 12/093398 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28792 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318995.pdf [firstpage_image] =>[orig_patent_app_number] => 12093398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121736 [patent_doc_number] => 07709469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'P2X7 receptor antagonists and methods of use' [patent_app_type] => utility [patent_app_number] => 11/593377 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28844 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709469.pdf [firstpage_image] =>[orig_patent_app_number] => 11593377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041241 [patent_doc_number] => 20070093523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Tetrahydroisoquinoline LXR modulators' [patent_app_type] => utility [patent_app_number] => 11/582784 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28709 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093523.pdf [firstpage_image] =>[orig_patent_app_number] => 11582784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112798 [patent_doc_number] => 07713989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-11 [patent_title] => 'Glucocorticoid receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/580996 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88268 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/713/07713989.pdf [firstpage_image] =>[orig_patent_app_number] => 11580996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989443 [patent_doc_number] => 20070155784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Novel nitrogen-containing heteroaryl compounds and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/549571 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48874 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155784.pdf [firstpage_image] =>[orig_patent_app_number] => 11549571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051983 [patent_doc_number] => 20070032528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/546814 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27898 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032528.pdf [firstpage_image] =>[orig_patent_app_number] => 11546814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5254009 [patent_doc_number] => 20070135465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Fab I Inhibitor and Process for Preparing Same' [patent_app_type] => utility [patent_app_number] => 11/548349 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27385 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135465.pdf [firstpage_image] =>[orig_patent_app_number] => 11548349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840418 [patent_doc_number] => 20080280904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/089136 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10425 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280904.pdf [firstpage_image] =>[orig_patent_app_number] => 12089136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5237233 [patent_doc_number] => 20070129390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4' [patent_app_type] => utility [patent_app_number] => 11/541205 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42229 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20070129390.pdf [firstpage_image] =>[orig_patent_app_number] => 11541205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172440 [patent_doc_number] => 20070072873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel thiophene derivatives which are HM74A agonists' [patent_app_type] => utility [patent_app_number] => 11/524145 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17202 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072873.pdf [firstpage_image] =>[orig_patent_app_number] => 11524145 [rel_patent_id] =>[rel_patent_doc_number] =>)